- Forte Biosciences experienced a 13 % increase in trading volume, with 655,893 shares changing hands and the stock trading at $76.7950.
- Several financial institutions adjusted their ratings and price objectives for the company, resulting in a consensus rating of Hold and an average target price of $72.50.
- Institutional investors and hedge funds, which own 77.63 % of the company's stock, recently adjusted their holdings in Forte Biosciences.